Commentary on ‘Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators’
Evidence-Based Child Health: A Cochrane Review Journal · 2006
DOI: 10.1002/ebch.12 ↗At a glance
Journal article in Evidence-Based Child Health: A Cochrane Review Journal, 2006. Written by Paul L P Brand. 8 references.
Topics: Kinderkrankenpflege
Abstract (original language)
This is a commentary on a Cochrane review, published in this issue of EBCH, first published as: Mitta A, Bassler D, Goodman K, Lasserson TJ, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD001276. DOI: 10.1002/14651858.CD001276.pub2. Copyright © 2006 John Wiley & Sons, Ltd.
Cite
APA
Brand, P. L. P. (2006). Commentary on ‘Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators’. Evidence-Based Child Health: A Cochrane Review Journal. https://doi.org/10.1002/ebch.12
Vancouver
Brand PLP. Commentary on ‘Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators’. Evidence-Based Child Health: A Cochrane Review Journal. 2006. doi:10.1002/ebch.12
BibTeX
@article{Brand2006,
author = {Brand, Paul L P},
title = {Commentary on ‘Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators’},
journal = {Evidence-Based Child Health: A Cochrane Review Journal},
year = {2006},
doi = {10.1002/ebch.12}
}
EUVIMED